High prevalence of clarithromycin resistant Helicobacter pylori in Turkish children with gastric disorders

被引:3
作者
Bahadori, Ali [1 ]
Gokmen, Tulin Guven [2 ]
Koksal, Fatih [3 ]
Tumgor, Gokhan [4 ]
Agin, Mehmet [4 ]
Sadighi, Ali [5 ]
Ziaee, Mojtaba [6 ]
Rahbarnia, Leila [7 ]
机构
[1] Sarab Fac Med Sci, Dept Med Microbiol, Sarab, Iran
[2] Cukurova Univ, Ceyhan Vet Fac, Dept Microbiol, Adana, Turkey
[3] Cukurova Univ, Fac Med, Dept Med Microbiol, Adana, Turkey
[4] Cukurova Univ, Dept Pediat Gastroenterol, Med Fac, Adana, Turkey
[5] Sarab Fac Med Sci, BSc Med Lab Sci, Student Res Comm, Sarab, Iran
[6] Maragheh Univ Med Sci, Med Plants Res Ctr, Maragheh, Iran
[7] Tabriz Univ Med Sci, Infect & Trop Dis Res Ctr, Tabriz, Iran
关键词
PCR-RFLP; Clarithromycin resistance; Helicobacter pylori; PEPTIC-ULCER; INFECTION; ERADICATION; SYMPTOMS;
D O I
10.1016/j.genrep.2021.101275
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objectives: Helicobacter pylori (H. pylori) is one of the leading cause of most gastroduodenal diseases. Commonly, clarithromycin is prescribed to treat H. pylori infections. Increasing resistance to clarithromycin is now one of the main problems of health worldwide. This study is aimed to survey clarithromycin resistant H. pylori infection in children with gastric disorders in Turkey. Patients and methods: A total of 110 biopsy samples were collected from the gastric antral of children referred to Balcali Hospital in Adana city, Turkey from October 2015 to November 2016. After the DNA extraction, a PCR reaction was performed for the detection of glmM gene as a diagnostic marker for Helicobacter. To examine resistance to clarithromycin, RFLP-PCR was performed to detect A2142G and A2143G point mutations in the 23SrRNA amplification product. Results: Based on histopathological and RUT tests and PCR, H. pylori was detected in 26.4% (29/110), 23.6% (26/ 110), and 33.6% (37/110) of the pediatric patients respectively. The frequency of H. pylori infection was dependent on age but independent of gender. The A2143G and A2142G point mutations were found in (n: 13, 61.90%) and (n: 8, 38.09%) of H. pylori isolates. Conclusion: Our findings highlight a high rate of resistance to clarithromycin in Turkish children with H. pylori infection. Hence, it is essential to note other classes of antibiotics except clarithromycin for the effective treatment of H. pylori infection in children younger than 18 years in the study region.
引用
收藏
页数:4
相关论文
共 28 条
[11]   Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance [J].
Kocazeybek, Bekir ;
Sakli, Merve Kutlu ;
Yuksel, Pelin ;
Demirci, Mehmet ;
Caliskan, Reyhan ;
Sarp, Tevhide Ziver ;
Saribas, Suat ;
Demiryas, Suleyman ;
Kalayci, Fatma ;
Cakan, Huseyin ;
Uysal, Hayriye Kirkoyun ;
Gareayaghi, Nesrin ;
Ergin, Sevgi ;
Erzin, Yusuf Ziya ;
Bal, Kadir ;
Tasci, Ihsan ;
Tokman, Hrisi Bahar .
JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (04) :566-573
[12]   Diagnosis of Helicobacter pylori by invasive test: histology [J].
Lee, Ju Yup ;
Kim, Nayoung .
ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (01)
[13]   Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori [J].
Li, Min ;
Oshima, Tadayuki ;
Horikawa, Tomoki ;
Tozawa, Katsuyuki ;
Tomita, Toshihiko ;
Fukui, Hirokazu ;
Watari, Jiro ;
Miwa, Hiroto .
HELICOBACTER, 2018, 23 (04)
[14]   Systematic review of the relationship of Helicobacter pylori infection with geographical latitude, average annual temperature and average daily sunshine [J].
Lu, Chao ;
Yu, Ye ;
Li, Lan ;
Yu, Chaohui ;
Xu, Ping .
BMC GASTROENTEROLOGY, 2018, 18
[15]  
Maçin S, 2015, TURKISH J PEDIATR, V57, P254
[16]   Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report [J].
Malfertheiner, P. ;
Megraud, F. ;
O'Morain, C. A. ;
Gisbert, J. P. ;
Kuipers, E. J. ;
Axon, A. T. ;
Bazzoli, F. ;
Gasbarrini, A. ;
Atherton, J. ;
Graham, D. Y. ;
Hunt, R. ;
Moayyedi, P. ;
Rokkas, T. ;
Rugge, M. ;
Selgrad, M. ;
Suerbaum, S. ;
Sugano, K. ;
El-Omar, E. M. .
GUT, 2017, 66 (01) :6-30
[17]   Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption [J].
Megraud, Francis ;
Coenen, Samuel ;
Versporten, Ann ;
Kist, Manfred ;
Lopez-Brea, Manuel ;
Hirschl, Alexander M. ;
Andersen, Leif P. ;
Goossens, Herman ;
Glupczynski, Youri ;
Alarcon, T. ;
Albrecht, P. ;
Barna, Z. ;
Burucoa, C. ;
Calvet, X. ;
Cambau, E. ;
Cellini, L. ;
Conroy, M-C ;
Deforges, L. ;
Dzierzanowska-Fangrat, K. ;
Franzin, L. ;
Gisbert, J. ;
Gosciniak, G. ;
Huang, Te-Din ;
Jeverica, S. ;
Kuipers, E. ;
Kupcinskas, L. ;
Lario, S. ;
Lawson, A. ;
Marzio, L. ;
McNulty, C. ;
Melby, K. ;
Mentis, A. ;
Monno, R. ;
Montes, M. ;
Oleastro, M. ;
O'Morain, C. ;
Pellicano, R. ;
Perez-Trallero, E. ;
Pieramico, O. ;
Rasmussen, L. ;
Raymond, J. ;
Royo, G. ;
Stoof, J. ;
Szkaradkiewicz, A. ;
Taneike, I ;
Tonkic, M. ;
Villar, Perez H. ;
Wueppenhorst, N. ;
Zanetti, M. .
GUT, 2013, 62 (01) :34-42
[18]  
Montazer-Saheb S, 2011, AFR J MICROBIOL RES, V5, P3616
[19]  
Nejad MR, 2011, ARCH IRAN MED, V14, P115
[20]   Helicobacter pylori infection in Turkish children:: Comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication [J].
Özçay, F ;
Koçak, N ;
Temizel, INS ;
Demir, H ;
Özen, H ;
Yüce, A ;
Gürakan, F .
HELICOBACTER, 2004, 9 (03) :242-248